(2S,4R)-Methyl 4-hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl)butanoyl)pyrrolidine-2-carboxylate, 98%, 50mg

5,5'-(2,5-FURANDIYL)BIS-2-THIOPHENEMETHANOL, 95.0%, 100mg

Hexapeptide-10, 98%, 100mg

Ethyl 6-((tert-butoxycarbonyl)amino)spiro[3.3]heptane-2-carboxylate, 95.0%, 100mg

(Polystyrylmethyl)trimethylammonium Cyanoborohydride cross-linked with 10% DVB (30-50mesh) (2.6-3.0mmol/g)5g

Methyl 2-(4-aminophenyl)-2-hydroxyacetate, 98%, 100mg

2-Ethyl-6-methylphenol, 97.0%, 1g

(R)-1-(3,5-Bis-trifluoromethyl-phenyl)-ethanol, 97.0%, 100g

(3-NITRO-PYRIDIN-2-YLAMINO)-ACETIC ACID, 97.0%, 1g

2-[4-(1-Methyl-1-phenylethyl)phenoxy]-acetohydrazide, 95.0%, 1g

Isopropyl palmitate, min. 90%, for synthesis, 1 l, plastic packaging.

1-Methyl-1H-indol-7-amine, 98%, 100mg

6-Fluorochromane-2-carboxylic acid, 97.0%, 10g